Your browser doesn't support javascript.
loading
Cross-sectional surveillance study of long COVID in Toyonaka city, Osaka prefecture, Japan.
Kutsuna, Satoshi; Onozuka, Daisuke; Asano, Kento; Matsunami, Katsura; Matsuoka, Taro.
Afiliação
  • Kutsuna S; Department of Infection Control and Prevention, Graduate School of Medicine, Faculty of Medicine, Osaka University, Osaka, Japan. Electronic address: kutsuna@hp-infect.med.osaka-u.ac.jp.
  • Onozuka D; Department of Oral Microbe Control, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Asano K; Academic Clinical Research Center, Department of Medical Innovation, Osaka University Hospital, Osaka, Japan.
  • Matsunami K; Toyonaka City Public Health Center, Osaka, Japan.
  • Matsuoka T; Toyonaka City Public Health Center, Osaka, Japan.
J Infect Chemother ; 30(6): 511-515, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38103867
ABSTRACT

BACKGROUND:

As the COVID-19 epidemic continues, concerns about long-term health impacts, specifically long COVID, persist. While the prevalence and symptomatology of long COVID have been explored in various global contexts, large-scale cohort studies in Japan remain limited, especially after the advent of the Omicron variant.

METHODS:

In this observational study, 4,047 residents with a history of COVID-19 living in Toyonaka City, Osaka Prefecture, were assessed for long COVID symptoms using the VOICE mobile application and a paper survey. Respondents provided demographic and health information, as well as information regarding COVID-19 infection and subsequent symptoms. A Cox proportional hazard regression model was used to estimate the multivariable-adjusted hazard ratios and 95 % confidence intervals for overall morbidity of long COVID symptoms.

RESULTS:

The survey found that 5.2 % of participants reported the persistence of one or more symptoms at 30 days post-onset. Fatigue was the most commonly reported symptom (1.75 %), followed by hair loss (1.41 %), and cough (1.28 %). Factors associated with an increased risk of experiencing long COVID symptoms included BMI, severe illness during the acute phase, and infection with certain COVID-19 variant strains, including Alpha, Delta, and Omicron. However, the incidence rate of long COVID appears to be decreasing with the dominance of the Omicron variant.

CONCLUSIONS:

This large-scale study from Toyonaka City suggests a 5.2 % prevalence rate for persistent COVID-19 symptoms 4 weeks post-infection, potentially indicating a lower prevalence of long COVID in Japanese populations after the rise of the Omicron variant.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Síndrome de COVID-19 Pós-Aguda Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Infect Chemother Assunto da revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Síndrome de COVID-19 Pós-Aguda Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Infect Chemother Assunto da revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2024 Tipo de documento: Article